Uranium (UROY) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 4, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Jul 28, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UROY SEC filings page.
Uranium (UROY) reported $186.8M in revenue for fiscal year 2026, up 1566.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Uranium Royalty Corp.’s dominant mechanic is a pivot from loss-making operations to working-capital-amplified profitability.
Cash conversion materially exceeded accounting profit in FY2026: operating cash flow reached$178.5M against net income of$40.2M , while inventory fell from$157.6M in FY2025 to$34.3M . That combination indicates cash was helped substantially by working-capital unwinding, so the period’s cash release was not explained by earnings alone.
Profitability changed shape: gross margin recovered from
The balance sheet remains lightly levered at 0.2x debt-to-equity, so liabilities are not primarily a debt burden. Current liabilities expanded to
Financial Health Signals
Scored against energy companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Uranium's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Uranium has an operating margin of 25.9%, meaning the company retains $26 of operating profit per $100 of revenue. This below-average margin results in a low score of 29/100, suggesting thin profitability after operating expenses. This is up from -30.7% the prior year.
Uranium's revenue surged 1566.0% year-over-year to $186.8M, reflecting rapid business expansion. This strong growth earns a score of 98/100.
Uranium carries a low D/E ratio of 0.19, meaning only $0.19 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 5.94, Uranium holds $5.94 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 94/100.
Not available for Uranium, and counted as zero in the overall score.
Uranium's ROE of 12.9% shows moderate profitability relative to equity, earning a score of 50/100. This is up from -2.1% the prior year.
Uranium scores 18.77, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($1.7B) relative to total liabilities ($60.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Uranium passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Uranium generates $4.43 in operating cash flow ($178.5M OCF vs $40.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2026.
Cash & Balance Sheet
Uranium held $242.0M in cash as of Q4 2026; long-term debt is not reported for that period.
Not reported for Q4 2026.
Not reported for Q4 2026.
Margins & Returns
None of these metrics is reported for Q4 2026.
Capital Allocation
None of these metrics is reported for Q4 2026.
UROY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
UROY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q4'2510-K |
|---|---|---|
| Total Assets | $373.3M+72.7% | $216.1M |
| Current Assets | $329.3M+90.8% | $172.6M |
| Cash & Equivalents | $242.0M+2481.1% | $9.4M |
| Short-Term Investments | $0 | $0 |
| Inventory | $34.3M-78.2% | $157.6M |
| Accounts Receivable | $59K+90.3% | $31K |
| Long-Term Investments | $0 | $0 |
| Total Liabilities | $60.5M+5859.6% | $1.0M |
| Current Liabilities | $55.5M+7406.9% | $739K |
| Non-Current Liabilities | $5.1M+1731.8% | $277K |
| Total Equity | $312.8M+45.4% | $215.1M |
| Retained Earnings | $52.5M+329.8% | $12.2M |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
UROY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
UROY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Uranium UROY | FY2026 | $186.8M | $40.2M | 21.6% | $1.7B | 58/100 |
| Encore Energy EU | FY2025 | $43.2M | -$56.9M | N/A | $244.8M | 51/100 |
| Ur-Energy URG | FY2025 | $27.2M | -$74.9M | N/A | $557.0M | 41/100 |
| Uranium Energy UEC | FY2025 | $66.8M | -$87.7M | N/A | $5.7B | 35/100 |
| Energy Fuels UUUU | FY2025 | $65.9M | -$86K | -0.1% | $3.8B | 48/100 |
| Denison Mines DNN | FY2017 | $11.1M | -$14.2M | N/A | $3.1B | — |
Where Uranium Ranks
Frequently Asked Questions
What is Uranium's annual revenue?
Uranium (UROY) reported $186.8M in total revenue for fiscal year 2026. This represents a 1566.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Uranium's revenue growing?
Uranium (UROY) revenue grew by 1566.0% year-over-year, from $11.2M to $186.8M in fiscal year 2026.
Is Uranium profitable?
Yes, Uranium (UROY) reported a net income of $40.2M in fiscal year 2026, with a net profit margin of 21.6%.
What is Uranium's EBITDA?
Uranium (UROY) had EBITDA of $48.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Uranium's gross margin?
Uranium (UROY) had a gross margin of 30.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Uranium's operating margin?
Uranium (UROY) had an operating margin of 25.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Uranium's net profit margin?
Uranium (UROY) had a net profit margin of 21.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Uranium's return on equity (ROE)?
Uranium (UROY) has a return on equity of 12.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Uranium's operating cash flow?
Uranium (UROY) generated $178.5M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Uranium's total assets?
Uranium (UROY) had $373.3M in total assets as of fiscal year 2026, including both current and long-term assets.
What is Uranium's current ratio?
Uranium (UROY) had a current ratio of 5.94 as of fiscal year 2026, which is generally considered healthy.
What is Uranium's debt-to-equity ratio?
Uranium (UROY) had a debt-to-equity ratio of 0.19 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Uranium's return on assets (ROA)?
Uranium (UROY) had a return on assets of 10.8% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Uranium's P/E ratio?
Uranium (UROY) trades at 42.0x earnings, its market capitalization divided by net income of $40.2M net income, FY2026. The market capitalization is $1.7B as of Sep 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Uranium's price-to-sales ratio?
Uranium (UROY) trades at 9.1x sales, its market capitalization divided by revenue of $186.8M revenue, FY2026. The market capitalization is $1.7B as of Sep 4, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Uranium's Altman Z-Score?
Uranium (UROY) has an Altman Z-Score of 18.77, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Uranium's Piotroski F-Score?
Uranium (UROY) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Uranium's earnings high quality?
Uranium (UROY) has an earnings quality ratio of 4.43x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Uranium?
Uranium (UROY) scores 58 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.